Development and validation of a nomogram model for predicting the risk of venous thromboembolism in lymphoma patients undergoing chemotherapy: a prospective cohort study conducted in China

References

• Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2020;38(5):1–9. doi: 10.1200/JCO.19.01461.
   PubMed Web of Science ®Google Scholar
• Bartholomew JR. Update on the management of venous thromboembolism. Cleve Clin J Med. 2017;84(12 Suppl 3):39–46. doi: 10.3949/ccjm.84.s3.04.
   PubMedGoogle Scholar
• Cronin-Fenton DP, Sondergaard F, Pedersen LA, et al. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer. 2010;103(7):947–953. doi: 10.1038/sj.bjc.6605883.
   PubMed Web of Science ®Google Scholar
• Chew SH, Achmad Sankala HB, Chew E, et al. Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study. Mult Scler Relat Disord. 2023;79:104992. doi: 10.1016/j.msard.2023.104992.
   PubMed Web of Science ®Google Scholar
• Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251(2):344–350. doi: 10.1097/SLA.0b013e3181b7fca6.
   PubMed Web of Science ®Google Scholar
• Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902–4907. doi: 10.1182/blood-2007-10-116327.
   PubMed Web of Science ®Google Scholar
• Li J, Qiang WM, Wang Y, et al. Development and validation of a risk assessment nomogram for venous thromboembolism associated with hospitalized postoperative Chinese breast cancer patients. J Adv Nurs. 2021;77(1):473–483. doi: 10.1111/jan.14571.
   PubMed Web of Science ®Google Scholar
• Wang L, Wei S, Zhou B, et al. A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors. Thromb Res. 2021;202:52–58. doi: 10.1016/j.thromres.2021.02.035.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou H, Zhong G, et al. Development and validation of a nomogram to predict the probability of venous thromboembolism in patients with epithelial ovarian cancer. Clin Appl Thromb Hemost. 2022;28:10760296221095558. doi: 10.1177/10760296221095558.
   Web of Science ®Google Scholar
• Zhang HR, Xu MY, Yang XG, et al. Nomogram for predicting the postoperative venous thromboembolism in spinal metastasis tumor: a multicenter retrospective study. Front Oncol. 2021;11:629823. doi: 10.3389/fonc.2021.629823.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang Y, Yang P, et al. A novel nomogram based on prognostic factors for predicting venous thrombosis risk in lymphoma patients. Leuk Lymphoma. 2021;62(10):2383–2391. doi: 10.1080/10428194.2021.1913149.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lei H, Wang W, et al. Characteristics and predictors of venous thromboembolism among lymphoma patients undergoing chemotherapy: a cohort study in China. Front Pharmacol. 2022;13:901887. doi: 10.3389/fphar.2022.901887.
   PubMed Web of Science ®Google Scholar
• Lei H, Tao D, Zhang N, et al. Nomogram prediction for the risk of venous thromboembolism in patients with lung cancer. Cancer Cell Int. 2023;23(1):40. doi: 10.1186/s12935-023-02882-1.
   PubMed Web of Science ®Google Scholar
• Kekre N, Connors JM. Venous thromboembolism incidence in hematologic malignancies. Blood Rev. 2019;33:24–32. doi: 10.1016/j.blre.2018.06.002.
   PubMed Web of Science ®Google Scholar
• Zhou H, Hu Y, Li X, et al. Assessment of the risk of venous thromboembolism in medical inpatients using the Padua prediction score and Caprini risk assessment model. J Atheroscler Thromb. 2018;25(11):1091–1104. doi: 10.5551/jat.43653.
   PubMed Web of Science ®Google Scholar
• Park SY. Nomogram: an analogue tool to deliver digital knowledge. J Thorac Cardiovasc Surg. 2018;155(4):1793. doi: 10.1016/j.jtcvs.2017.12.107.
   PubMed Web of Science ®Google Scholar
• Guntupalli SR, Spinosa D, Wethington S, et al. Prevention of venous thromboembolism in patients with cancer. BMJ. 2023;381:e072715. doi: 10.1136/bmj-2022-072715.
   PubMedGoogle Scholar
• Richie CD, Castle JT, Davis GA, et al. Modes of failure in venous thromboembolism prophylaxis. Angiology. 2022;73(8):712–715. doi: 10.1177/00033197221083724.
   PubMed Web of Science ®Google Scholar
• Caruso V, Di Castelnuovo A, Meschengieser S, et al. Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events. Blood. 2010;115(26):5322–5328. doi: 10.1182/blood-2010-01-258624.
   PubMed Web of Science ®Google Scholar
• Antic D, Jelicic J, Vukovic V, et al. Venous thromboembolic events in lymphoma patients: Actual relationships between epidemiology, mechanisms, clinical profile and treatment. Blood Rev. 2018;32(2):144–158. doi: 10.1016/j.blre.2017.10.002.
   PubMed Web of Science ®Google Scholar
• Schmidt RA, Lee AYY. How I treat and prevent venous thrombotic complications in patients with lymphoma. Blood. 2022;139(10):1489–1500. doi: 10.1182/blood.2019003689.
   PubMed Web of Science ®Google Scholar
• Borchmann S, Müller H, Hude I, et al. Thrombosis as a treatment complication in hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin study group (GHSG) trials. Ann Oncol. 2019;30(8):1329–1334. doi: 10.1093/annonc/mdz168.
   PubMed Web of Science ®Google Scholar
• Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464–474. doi: 10.1038/nrcardio.2015.83.
   PubMed Web of Science ®Google Scholar
• Oppelt P, Betbadal A, Nayak L. Approach to chemotherapy-associated thrombosis. Vasc Med. 2015;20(2):153–161. doi: 10.1177/1358863X14568705.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lim KM, Noh JY, et al. Doxorubicin-induced platelet procoagulant activities: an important clue for chemotherapy-associated thrombosis. Toxicol Sci. 2011;124(1):215–224. doi: 10.1093/toxsci/kfr222.
   PubMed Web of Science ®Google Scholar